Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Beneficial effects of isovolemic hemodilution using a perfluorocarbon emulsion in a stroke model

Article Abstract:

Stroke, or cerebrovascular accident, is a sudden loss of consciousness followed by paralysis. It is caused by closure of an artery or cerebrovascular hemorrhage, which results in ischemia (deficiency of blood supply) to brain tissue normally passed thru by the damaged or closed vessels. Cerebral infarction (death of an area of brain tissue following cessation of blood supply) appears to be initiated by oxygen deprivation. Blood flow studies and computed tomographic scans suggest that the area of infarction extends outward from a central point, damaging the areas surrounding the infarction, where metabolic and electrical malfunctions occur. If damage to this surrounding area could be avoided, the resulting functional disability, such as paralysis, might be decreased. It may be helpful to provide oxygen to the ischemic area surrounding the infarct by increasing the blood flow to it. Attempts have been made to increase blood flow to the brain by hemodilution (diluting the blood to decrease its viscosity and increase its flow). If the substance used to dilute the blood also can markedly increase oxygen delivery, rescue of brain cells threatened with ischemic damage may be achieved. Intravenous administration of a perfluorocarbon emulsion (a blood substitute with oxygen-carrying ability) may provide this increased supply of oxygen. A study was carried out on cats to determine the benefit of hemodilution with a perfluorocarbon emulsion or dextran following induced stroke. The findings revealed that the cats treated with the perfluorocarbon emulsion had less brain swelling in the early postinfarction period and a higher level of oxidation of cytochrome aa3, indicating better well-being of cells surrounding the infarct and threatened with ischemia, than did the animals treated with dextran. These findings indicate that treatment with an oxygen-carrying substance used for hemodilution may be helpful in treating strokes. (Consumer Summary produced by Reliance Medical Information, Inc.)

Author: Kline, Ronald A., Negendank, William, McCoy, Lowell, Berguer, Ramon
Publisher: Elsevier B.V.
Publication Name: American Journal of Surgery
Subject: Health
ISSN: 0002-9610
Year: 1991
Care and treatment, Models, Physiological aspects, Brain, Cerebral ischemia, Infarction, Brain infarction

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Near-fatal heat stroke during the 1995 heat wave in Chicago

Article Abstract:

People who develop severe heat stroke have a high mortality rate even after hospital discharge and may never fully recover. Researchers followed 58 patients who were admitted to an intensive care unit during the heat wave that hit Chicago in July, 1995. All developed dysfunction of many organs in the ICU and half developed kidney failure. Twenty-one percent died in the hospital. Thirty-three percent were moderately to severely disabled at discharge. One year after discharge, an additional 28% had died and most had not improved since their hospitalization.

Author: Whitney, Cynthia G., Dematte, Jane E., O'Mara, Karen, Buescher, Jennifer, Forsythe, Sean, McNamee, Turi, Adiga, Raghavendra B., Ndukwu, I. Maurice
Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1998
Prognosis, Environmental aspects, Chicago, Illinois, Illinois, Heat waves (Meteorology), Warm fronts, Heatstroke

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Alteplase for thrombolysis in acute ischemic stroke

Article Abstract:

Prompt administration of intravenous alteplase (Activase), a recombinant tissue plasminogen activator, may improve the outcome of acute ischemic stroke. Ischemic stroke occurs when a blood clot travels to the brain, blocking part of the blood supply. However, this thrombolytic treatment causes some patients to develop intracranial bleeding and no clear survival advantage has been established. It is important to rule out hemorrhagic stroke prior to the use of alteplase.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1996
Evaluation, Product/Service Evaluation, Drug therapy, Tissue plasminogen activator, Activase (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Stroke (Disease), Stroke
Similar abstracts:
  • Abstracts: Effect of bromocriptine on sperm function in vitro and in vivo. In vitro fertilization
  • Abstracts: Effects of life-style modification on serum lipids. Atorvastatin -- a new lipid-lowering drug
  • Abstracts: Zinc deficiency: a public health problem? Salt consumption in Ancient Polynesia. Zinc for the common cold
  • Abstracts: Median and ulnar neuropathy after streptokinase infusion. Itching for a solution
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.